Company page
Cellectis S.a.
Cellectis S.A. is a public biotechnology company based in France, focusing on developing innovative gene-editing technologies. The company is traded on the stock market under the ticker ALCLS and has a market capitalization of approximately €223.4 million. Cellectis aims to advance its research and applications in the field of genetic engineering.
- Ticker
- ALCLS:EURONEXT
- Asset type
- Stock
- Market cap
- $223.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR